Posts with this category are annual summaries of IPO board resolutions.
Resolution Opposing the Medication Affordability and Patent Integrity Act (S.2780)
RESOLVED, IPO opposes the Medication Affordability and Patent Integrity Act [...]
Resolution Related to DOCX Filings
RESOLVED, that IPO supports the USPTO’s transition to DOCX filing [...]
Resolution Regarding the Affordable Prescriptions for Patients Act of 2023
Resolved, that IPO opposes the Affordable Prescriptions for Patients Act [...]
Resolution Related to Anti-Suit Injunctions
RESOLVED, that IPO believes that an anti-suit injunction (ASI)should not [...]
Resolution Related to USPTO-FDA Collaboration
RESOLVED, IPO opposes The Interagency Patent Coordination and Improvement Act [...]
Resolution Relating to Transparency of Decisions
RESOLVED that IPO generally supports transparency including publishing of judicial [...]
Resolution Related to Public Collections of Genetic Digital Sequence Information (DSI)
RESOLVED, IPO believes that unrestricted access to public collections of [...]
Resolution Related to Genetic Resources and Traditional Knowledge
RESOLVED, IPO reaffirms its belief that special disclosure requirements for [...]
Resolution Supporting In Principle the INFORM Consumers Act of 2021
RESOLVED, that IPO supports, in principle, federal legislation requiring online [...]
Resolution Supporting In Principle the SHOP SAFE Act of 2021
RESOLVED, that IPO supports, in principle, legislation to amend the [...]
